01 Jul 2019
Southeastern team up with the University of Kent to raise awareness and offer passengers free health-check whilst travelling in the hotter summer months.
For further information contact
Southeastern Press Office
0207 620 5080 (24-hours)
press.office@southeasternrailway.co.uk
The offer:
Customers can buy Off-Peak Day Return tickets from London (zones 1-6) to 13 selected destinations for a fixed price of £15, £20 or £25.
About Southeastern
Southeastern runs train services into London from Kent and East Sussex, operating over 2000 trains a day, carrying more than 640,000 passengers a day, serving 176 stations and covering 540-miles of railway infrastructure.
Southeastern is owned by Govia, a joint venture between the Go-Ahead Group (65 per cent) and Keolis (35 per cent). Govia is the most enduring partnership between transport operators delivering rail franchises in this country.
It is the UK’s busiest rail operator, responsible for 28.7 per cent of UK passenger rail journeys through its four rail companies, Southern, Southeastern, Govia Thameslink Railway and London Midland. Further information on Govia is available at: www.govia.info Go-Ahead Group plc is one of the UK's leading providers of passenger transport services operating in the bus, rail and aviation services sectors.
Keolis is a French-based operator of transport services in 13 countries worldwide and is owned by SNCF, AXA Private Equity, Caisse de dépôt et placement du Québec, and Keolis management.
About The University of Kent’s School of Sport and Exercise Sciences
The University of Kent’s School of Sport and Exercise Sciences is one of the leading sports science schools in the UK. Inspirational lecturers, cutting-edge research and world-class facilities create a stimulating environment for its students. The School is passionate about sport and the science behind it. The range of its research is broad. The School works with elite athletes and international sports bodies but also focus on the rehabilitation of cardiac and stroke patients and works with people with Parkinson's.